GGrantIndex
← Leaderboards

Juan Fueyo

University Of Tx Md Anderson Can Ctr

Google Scholar ↗PubMed ↗ORCID ↗
$8,546,462
Attributed
$9,775,892
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$24,353,815 · 14

By mechanism

P50$20,690,989 · 10
R01$3,433,517 · 3
R21$229,309 · 1

Top collaborators

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Brain Neoplasms”

Research focus

Brain NeoplasmsMalignant Neoplasm Of BrainProgramsGliomaClinical TrialsTumorOncolytic VirusesVirusFundingSuccessTranslatingOncolysisResearch PersonnelOperative Surgical ProceduresBiologicalUniversity Of Texas M D Anderson Cancer CenterImmuneFosteringViralGrantAwardMalignant GliomaMediatingBase

Grant awards (52)

SPORE in Brain Cancer$2,171,252
P50 · FY2025 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$370,575
R01 · FY2025 · CA · contact PI
Project 1: Combine Viro-Immunotherapy and Natural Killer Cells for the Treatment of Gliomas$327,626
P50 · FY2025 · CA · contact PI
Examining the Role of Nono Pathway on the Innate Immunity Against Oncolytic Adenoviruses$229,309
R21 · FY2025 · CA
Developmental Research Program (DRP)$225,298
P50 · FY2025 · CA · contact PI
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$81,881
R01 · FY2025 · CA · contact PI
Career Enhancement Program (CEP)$81,602
P50 · FY2025 · CA · contact PI
SPORE in Brain Cancer$2,088,365
P50 · FY2024 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$352,047
R01 · FY2024 · CA · contact PI
Project 1: Combine Viro-Immunotherapy and Natural Killer Cells for the Treatment of Gliomas$339,949
P50 · FY2024 · CA · contact PI
Developmental Research Program (DRP)$233,774
P50 · FY2024 · CA · contact PI
Career Enhancement Program (CEP)$84,673
P50 · FY2024 · CA · contact PI
NCI Diversity Supplement: Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$69,324
R01 · FY2024 · CA · contact PI
SPORE in Brain Cancer$2,051,421
P50 · FY2023 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$363,164
R01 · FY2023 · CA · contact PI
SPORE in Brain Cancer$2,051,421
P50 · FY2022 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$363,164
R01 · FY2022 · CA · contact PI
Developmental Research Program (DRP)$215,829
P50 · FY2022 · CA · contact PI
Career Enhancement Program (CEP)$87,150
P50 · FY2022 · CA · contact PI
SPORE in Brain Cancer$2,051,421
P50 · FY2021 · CA
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants$370,575
R01 · FY2021 · CA · contact PI
Off-the-shelf Genetically Engineered Natural Killer Therapy for Glioblastoma$258,822
P50 · FY2021 · CA
Developmental Research Program (DRP)$188,355
P50 · FY2021 · CA · contact PI
Career Enhancement Program (CEP)$76,056
P50 · FY2021 · CA · contact PI
SPORE in Brain Cancer$2,094,780
P50 · FY2020 · CA
Developmental Research Program (DRP)$220,065
P50 · FY2020 · CA · contact PI
Career Enhancement Program (CEP)$81,550
P50 · FY2020 · CA · contact PI
SPORE in Brain Cancer$2,069,263
P50 · FY2019 · CA
Developmental Research Program (DRP)$216,071
P50 · FY2019 · CA · contact PI
Career Enhancement Program (CEP)$87,253
P50 · FY2019 · CA · contact PI
Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain Tumors$307,898
P50 · FY2017 · CA · contact PI
Career Development Program$145,683
P50 · FY2017 · CA · contact PI
Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain Tumors$289,574
P50 · FY2016 · CA · contact PI
Career Development Program$136,686
P50 · FY2016 · CA · contact PI
Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain Tumors$295,133
P50 · FY2015 · CA · contact PI
Career Development Program$138,397
P50 · FY2015 · CA · contact PI
Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain Tumors$283,947
P50 · FY2014 · CA · contact PI
Career Development Program$136,941
P50 · FY2014 · CA · contact PI
Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain Tumors$285,917
P50 · FY2013 · CA · contact PI
Career Development Program$135,282
P50 · FY2013 · CA · contact PI
Tropism Enhanced Oncolytic Adenovirus for the treatment of Brain Tumors$264,692
P50 · FY2012 · CA · contact PI
Tropism Enhanced Oncolytic Adenovirus for the treatment of Brain Tumors$262,278
P50 · FY2011 · CA · contact PI
Tropism Enhanced Oncolytic Adenovirus for the treatment of Brain Tumors$263,841
P50 · FY2010 · CA · contact PI
Tropism Enhanced Oncolytic Adenovirus for the treatment of Brain Tumors$262,691
P50 · FY2009 · CA · contact PI
Tropism Enhanced Oncolytic Adenovirus for the treatment of Brain Tumors$180,033
P50 · FY2008 · CA · contact PI
Conditional Replicating Adenovirus for Glioma Treatment$210,118
R01 · FY2006 · CA · contact PI
Conditional Replicating Adenovirus for Glioma Treatment$215,175
R01 · FY2005 · CA
Conditional Replicating Adenovirus for Glioma Treatment$215,175
R01 · FY2004 · CA
Conditional Replicating Adenovirus for Glioma Treatment$215,175
R01 · FY2003 · CA
Conditional Replicating Adenovirus for Glioma Treatment$215,175
R01 · FY2002 · CA
MULTIPLE GENE CARRIER ADENOVIRAL CONSTRUCTS FOR GLIOMAS$198,233
R01 · FY2001 · CA
MULTIPLE GENE CARRIER ADENOVIRAL CONSTRUCTS FOR GLIOMAS$193,736
R01 · FY2000 · CA